Conduct a literature review over the last decade on targeting surviving, NRF2, and HIF1a/HIF2a for renal cancer treatment.
Literature review over the last decade on targeting surviving, NRF2, and HIF1a/HIF2a for renal cancer treatment. Focus is therapeutics and how targeting these proteins is important to better treat renal cancer. References should be included following APA style